Clinical Trial Update: Miglustat in Niemann-Pick Type C Disease [Phase 2]

View source ↗

Summary

Phase 2 trial of miglustat for Niemann-Pick disease type C has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Niemann-pick Disease Type

Drugs mentioned

• Zavesca (Miglustat)

Snippet

Sponsor: Actelion | Conditions: Niemann-Pick Type C Disease | Phase 2 | Status: COMPLETED